2017 Annual Meeting | C59 - Cerebrovascular Disease III: Acute Ischemic Stroke

Date Sunday 04/23/17

Time 03:30 PM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Philip B. Gorelick, MD, MPH, FAAN

Topic(s)

Learning Objectives Participants should be able to discuss proper application of evidence-based guidance for administration of intravenous alteplase (tPA) in acute ischemic stroke (AIS), discuss proper application of evidence-based guidance of other key medical therapies in AIS, and discuss proper application of endovascular interventions in AIS.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider

Teaching Styles Case-based, Didactic

Event Timeline
03:30 PM - 04:15 PM	Speaker	Use of of Intravenous Alteplase in Acute Ischemic Stroke Louis R. Caplan, MD, FAAN
04:15 PM - 04:30 PM	Q&A	Questions and Answers Louis R. Caplan, MD, FAAN
04:30 PM - 05:15 PM	Speaker	Case Examples of Evidence-based Application of Endovascular Therapy in Acute Ischemic Stroke Tudor G. Jovin, MD
05:15 PM - 05:30 PM	Q&A	Questions and Answers Tudor G. Jovin, MD

Faculty Disclosures
Louis R. Caplan, MD, FAAN	No disclosure on file
Tudor G. Jovin, MD	Dr. Jovin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Jovin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Contego Medical. Dr. Jovin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Several law firms. Dr. Jovin has stock in Corindus. Dr. Jovin has stock in Methinks. Dr. Jovin has stock in Viz.ai. Dr. Jovin has stock in Route92. Dr. Jovin has stock in FreeOx Biotech. Dr. Jovin has stock in Galaxy. Dr. Jovin has stock in Kandu. The institution of Dr. Jovin has received research support from Stryker. The institution of Dr. Jovin has received research support from Medtronic.
Philip B. Gorelick, MD, MPH, FAAN	Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Thorek Memorial Hospital. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Thorek Memorial Hospital.

��ɫ��

��ɫ��